Effectiveness of circulating tumor cells and circulating tumor DNA in peritoneal lavage fluid for predicting metachronous peritoneal metastasis of gastric cancer
Translational Research · 2025
DOI: 10.1016/j.trsl.2025.08.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2025. Verfasst von Long Bai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Adress:160 Pujian Road, Pudong N…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Circulating Tumor DNA, Neoplastic Cells, Circulating, Peritoneal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Jiao Tong University, National Natural Science Foundation of China, Shanghai Municipal Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Peritoneal metastasis is a leading cause of death in gastric cancer (GC) patients, highlighting the need for early diagnosis and high-risk population identification. While circulating tumor DNA(ctDNA) and circulating tumor cells (CTC) have been widely studied in blood, their role in peritoneal lavage fluid (PLF) remains unexplored. METHODS: Patients with stage III GC were enrolled, and preoperative/postoperative PLF was collected in this study. ctDNA in PLF supernatant was analyzed via next-generation sequencing (NGS), while CTC in the pellet were detected using Epithelial Cell Adhesion Molecule (EpCAM), Folate Receptor (FR), and Cytokeratin (CK) immunofluorescence. RESULTS: ctDNA-positive patients had higher peritoneal metastasis risk (preoperative HR: 4.82, 95% CI 1.03-22.54, p = 0.04; postoperative HR: 4.83, 95% CI 1.03-22.54, p = 0.04). CTC-positive patients also showed higher risk (preoperative HR: 6.76, 95% CI 0.92-49.74, p = 0.003; postoperative HR: 7.41, 95% CI 1.67-32.87, p = 0.02). Postoperative ctDNA had higher predictive efficacy for peritoneal metastasis compared to preoperative ctDNA, with AUC values of 0.93 and 0.86. Combined ctDNA/CTC positivity identified the highest recurrence risk (preoperative HR: 8.07, 95% CI 0.96-67.51, p = 0.0012; postoperative HR: 18.14, 95% CI 3.27-100.70, p = 0.0002). CONCLUSIONS: The combination of postoperative ctDNA and CTC in PLF offered the highest accuracy (85%) and risk stratification in predicting peritoneal metastasis (30.30% vs. 66.67%, p = 0.0063). This method may guide the postoperative prophylactic intraperitoneal chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Adress:160 Pujian Road, Pudong New Area, Shanghai, China.
- Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Adress:160 Pujian Road, Pudong New Area, Shanghai, China.
- Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Adress:160 Pujian Road, Pudong New Area, Shanghai, China. Electronic address: zebing080@163.com.
- Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Adress:160 Pujian Road, Pudong New Area, Shanghai, China. Electronic address: xiangmoumou@163.com.
- Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Adress:160 Pujian Road, Pudong New Area, Shanghai, China. Electronic address: zhangzizhen@renji.com.
Förderung
- Shanghai Jiao Tong University
- National Natural Science Foundation of China
- Shanghai Municipal Natural Science Foundation
- Shanghai Municipal Education Commission
- Shanghai Municipal Health Commission
Zitieren
APA
Bai, L., Ni, B., Shen, X., Zhang, Y., Guan, Y., Gu, J., Zhang, H., Aimaiti, M., Wang, S., Yue, B., Shen, Y., Liu, Z., Xia, X., & Zhang, Z. (2025). Effectiveness of circulating tumor cells and circulating tumor DNA in peritoneal lavage fluid for predicting metachronous peritoneal metastasis of gastric cancer. Translational Research. https://doi.org/10.1016/j.trsl.2025.08.003
Vancouver
Bai L, Ni B, Shen X, Zhang Y, Guan Y, Gu J, et al. Effectiveness of circulating tumor cells and circulating tumor DNA in peritoneal lavage fluid for predicting metachronous peritoneal metastasis of gastric cancer. Translational Research. 2025. doi:10.1016/j.trsl.2025.08.003
BibTeX
@article{Bai2025,
author = {Bai, Long and Ni, Bo and Shen, Xiaoyao and Zhang, Yeqian and Guan, Yujing and Gu, Jiayi and Zhang, Haoyu and Aimaiti, Muerzhate and Wang, Shuchang and Yue, Ben and Shen, Yanying and Liu, Zebing and Xia, Xiang and Zhang, Zizhen},
title = {Effectiveness of circulating tumor cells and circulating tumor DNA in peritoneal lavage fluid for predicting metachronous peritoneal metastasis of gastric cancer},
journal = {Translational Research},
year = {2025},
doi = {10.1016/j.trsl.2025.08.003}
}
EUVIMED